Which Is the Better Buy: iShares’ Pharma ETF IHE or First Trust’s Biotech Fund FBT?
iShares offers lower fees and smoother returns, while First Trust provides concentrated biotech exposure with higher growth potential.
Full story
Read the full story at The Motley Fool ↗
Continue reading this story on The Motley Fool, the publisher that reported it.
AI tools
Written by AI from the article text. It can make mistakes; check the original story.
